This hybrid hydrogel, where gelatin nanoparticles allow the co-release of BIO and IGF, not only improves cardiomyocyte proliferation and the subsequent cardiac function after MI due to the prolonged release of these factors but also provides mechanical properties specific to hydrogels [81]. The gene discussed is IGF1; the disease is myocardial infarction.